• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.

作者信息

Dadzie K Y, Remme J, De Sole G

机构信息

Onchocerciasis Control Programme in West Africa, Ouagadougou, Burkina Faso.

出版信息

Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):267-71. doi: 10.1016/0035-9203(91)90051-y.

DOI:10.1016/0035-9203(91)90051-y
PMID:1887490
Abstract

In a longitudinal study to determine the effect of annual community-based treatment of ocular onchocerciasis with ivermectin, the population living in the 3 most affected villages in the holo-endemic onchocerciasis focus of Asubende in Ghana were re-examined 16 and 24 months after initiating treatment. Ocular microfilarial loads had decreased to very low levels in nearly all of the 334 examined persons who were treated twice. Only very few subjects had ocular loads of 32 microfilariae or more in the anterior chamber of the eye, but this was not associated with deterioration of ocular lesions. Important regression of both early and advanced lesions of the anterior segment of the eye was observed, which was highly statistically significant with respect to iridocyclitis. Lesions of the posterior segment of the eye remained stable. Though no systematic change in the visual acuity of the population was observed, 3 new cases of blindness occurred in persons who already had eye lesions at such an advanced stage that ivermectin treatment could no longer affect the outcome. The results suggest that annual ivermectin treatment is adequate to control onchocercal ocular disease even in populations with very high endemicity levels.

摘要

相似文献

1
Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):267-71. doi: 10.1016/0035-9203(91)90051-y.
2
Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus.
Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):103-8. doi: 10.1016/0035-9203(90)90395-u.
3
Onchocerciasis in Ecuador: ocular findings in Onchocerca volvulus infected individuals.厄瓜多尔的盘尾丝虫病:盘尾丝虫感染个体的眼部检查结果
Br J Ophthalmol. 1995 Feb;79(2):157-62. doi: 10.1136/bjo.79.2.157.
4
Ivermectin treatment of patients with severe ocular onchocerciasis.伊维菌素治疗重度盘尾丝虫性眼病患者
Am J Trop Med Hyg. 1989 May;40(5):494-500. doi: 10.4269/ajtmh.1989.40.494.
5
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.使用伊维菌素控制盘尾丝虫病可降低视神经疾病的发病率。
Lancet. 1993 Jan 16;341(8838):130-4. doi: 10.1016/0140-6736(93)90002-x.
6
Onchocercal eye disease and the impact of Mectizan treatment.盘尾丝虫性眼病及美迪善治疗的影响。
Ann Trop Med Parasitol. 1998 Apr;92 Suppl 1:S11-22. doi: 10.1080/00034989859519.
7
Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.每半年使用伊维菌素治疗对墨西哥南部盘尾丝虫皮肤感染的患病率和强度、眼部病变以及赭色蚋种群传染性的影响。
Am J Trop Med Hyg. 1995 May;52(5):429-34.
8
Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.一项在治疗盘尾丝虫病中使用安慰剂对照的三剂量伊维菌素比较研究的眼科结果。
Trop Med Parasitol. 1989 Sep;40(3):355-60.
9
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.盘尾丝虫病的可持续控制:接受伊维菌素治疗23年的盘尾丝虫病患者的眼部病理学:一项队列研究
PLoS One. 2014 Jun 2;9(6):e98411. doi: 10.1371/journal.pone.0098411. eCollection 2014.
10
A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.伊维菌素每6个月、12个月和24个月给药一次治疗盘尾丝虫病的比较。
J Infect Dis. 1991 Feb;163(2):376-80. doi: 10.1093/infdis/163.2.376.

引用本文的文献

1
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.盘尾丝虫病的可持续控制:接受伊维菌素治疗23年的盘尾丝虫病患者的眼部病理学:一项队列研究
PLoS One. 2014 Jun 2;9(6):e98411. doi: 10.1371/journal.pone.0098411. eCollection 2014.
2
Applied field research for comprehensive helminth infection control.应用现场研究进行全面的寄生虫感染控制。
Wien Klin Wochenschr. 2010 Mar;122 Suppl 1:27-30. doi: 10.1007/s00508-010-1332-2.
3
Onchocerciasis: a potential risk factor for glaucoma.
盘尾丝虫病:青光眼的一个潜在风险因素。
Br J Ophthalmol. 2005 Jul;89(7):796-8. doi: 10.1136/bjo.2004.061895.
4
Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.西非盘尾丝虫病控制计划中伊维菌素联合年度治疗及病媒控制的所需持续时间。
Bull World Health Organ. 1997;75(3):237-45.